Coverage dated December 27, 2023 to December 28, 2023

New weight loss drugs are out of reach for millions of older Americans because Medicare won't pay

Headline from WMUR

Obesity drugs like Wegovy and Zepbound are capturing the attention of celebrities and showing promising results in helping people shed pounds.

WMUR's own description from its feed. We collect headlines and these descriptions, not full articles; read the original reporting below.

Reports & sources

34 articles, oldest first.

  1. Los Angeles Times

    New weight-loss drugs are out of reach for millions of older Americans because Medicare won't pay (opens Los Angeles Times)

    Published

    Los Angeles Times's feed description

    Obesity drugs like Wegovy and Zepbound are capturing the attention of celebrities and showing promising results in helping people shed pounds.

  2. WMUR

    New weight loss drugs are out of reach for millions of older Americans because Medicare won't pay (opens WMUR)

    Published

    WMUR's feed description

    Obesity drugs like Wegovy and Zepbound are capturing the attention of celebrities and showing promising results in helping people shed pounds.

  3. KEYT Santa Barbara

    New weight loss drugs are out of reach for millions of older Americans because Medicare won't pay | News Channel 3-12 (opens KEYT Santa Barbara)

    Published

    KEYT Santa Barbara's feed description

    New weight loss drugs are out of reach for millions of older Americans because Medicare won't pay

  4. PBS NewsHour

    Why new weight loss drugs are out of reach for millions of older Americans (opens PBS NewsHour)

    Published

    PBS NewsHour's feed description

    Obesity drugs like Wegovy and Zepbound are capturing the attention of celebrities and showing promising results in helping people shed pounds. But those drugs remain out of reach for millions of older Americans.

  5. The Oregonian

    New weight loss drugs out of reach for millions because Medicare won’t pay (opens The Oregonian)

    Published

    The Oregonian's feed description

    Drugmakers and a wide-ranging and growing bipartisan coalition of lawmakers are gearing up to push for that to change next year.

  6. Honolulu Star-Advertiser

    New weight loss drugs out of reach for millions of older Americans (opens Honolulu Star-Advertiser)

    Published

    Honolulu Star-Advertiser's feed description

    WASHINGTON >> New obesity drugs are showing promising results in helping some people shed pounds but the injections will remain out of reach for millions of older Americans because Medicare is forbidden to cover such medications.

  7. Green Field Reporter

    New weight loss drugs are out of reach for millions of older Americans because Medicare won't pay - The Daily Reporter (opens Green Field Reporter)

    Published

    Green Field Reporter's feed description

    WASHINGTON (AP) — New obesity drugs are showing promising results in helping some people shed pounds but the injections will remain out of reach for millions of older Americans because Medicare is forbidden to cover such medications.

  8. Fox10 Phoenix

    Millions of Americans can't obtain promising new weight loss drugs because Medicare won't pay (opens Fox10 Phoenix)

    Published

    Fox10 Phoenix's feed description

    Obesity drugs like Wegovy and Zepbound are capturing the attention of celebrities and showing promising results in helping people shed pounds.

  9. WHDH Boston

    New weight loss drugs are out of reach for millions of older Americans because Medicare won’t pay - Boston News, Weather, Sports (opens WHDH Boston)

    Published

    WHDH Boston's feed description

    WASHINGTON (AP) — New obesity drugs are showing promising results in helping some people shed pounds but the injections will remain out of reach for millions of

Identical headlines usually mean shared wire copy. They are counted as separate articles but are not independent confirmation.

New weight loss drugs are out of reach for millions of older Americans because Medicare won't pay | Since Then